The company has received final approval from the US Food Drug Administration (US FDA) for Saxagliptin Tablets (2.5 mg and 5 mg), the generic version of AstraZeneca#39;s Onglyza1 tablets, the Mumbai-based drug maker said in a statement.
The company has received final approval from the US Food Drug Administration (US FDA) for Saxagliptin Tablets (2.5 mg and 5 mg), the generic version of AstraZeneca#39;s Onglyza1 tablets, the Mumbai-based drug maker said in a statement. The company has received final approval from the US Food Drug Administration (US FDA) for Saxagliptin Tablets (2.5 mg and 5 mg), the generic version of AstraZeneca#39;s Onglyza1 tablets, the Mumbai-based drug maker said in a statement. Moneycontrol Latest News Read More
हिन्दी 
English